Precision Medicine Quarterly

Tempus xF Liquid Biopsy Assay Demonstrates Extensive Analytical and Clinical Validity in npj Precision Oncology Study

2021-07-14T07:59:04-05:00July 14th, 2021|

Tempus, a leader in artificial intelligence and precision medicine, today announced results from validation studies demonstrating the reliable analytical performance of the Tempus|xF liquid biopsy. When validated against methods such as ddPCR, the Roche AVENIO kit, and the Tempus|xT solid tumor assay, xF demonstrated high sensitivity and specificity for calling SNVs, indels, CNVs, and [...]

Novartis and Hewlett Packard Enterprise join forces to advance Novartis global health efforts

2021-07-14T07:56:30-05:00July 14th, 2021|

Novartis and Hewlett Packard Enterprise (HPE) today announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health and improve access to healthcare and medicines. The collaboration will focus on three global health enablers: identifying and integrating complex data sources related to health; advancing [...]

Dr. Eric Walk Joins PathAI as Chief Medical Officer

2021-07-14T07:53:42-05:00July 14th, 2021|

PathAI, a leading provider of AI-powered technology for advancing pathology research, announced that it has appointed Pathologist and executive leader Eric Walk, MD, FCAP, as Chief Medical Officer. "The PathAI team is excited to welcome Dr. Eric Walk onto our leadership team," said Andrew Beck. "Eric brings decades of experience working in the global [...]

Thermo Fisher Scientific Expands Corporate Leadership Team

2021-07-11T18:47:39-05:00July 11th, 2021|

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has announced that Alan Sachs, who has served as chief scientific officer (CSO) since 2016, will assume the newly established role of chief medical officer (CMO) and will be succeeded by Karen E. Nelson, previously president of the J. Craig Venter Institute. Both [...]

Go to Top